Strategic management plan for Optaderm Pharma, Inc.

Date of Publication

2006

Document Type

Oral Comprehensive Exam

Degree Name

Master of Business Administration

College

Ramon V. Del Rosario College of Business

Department/Unit

Decision Sciences and Innovation

Defense Panel Chair

Elfren S. Cruz

Abstract/Summary

The objective of this plan is to come up with a comprehensive strategic management plan for Optaderm Pharma, Inc., which will lay the foundation for the success of the company in the future. To succeed in the environment of the future, the company must undergo significant changes to adapt to the challenges it will face in the coming years.

Present Task Environment of Optaderm.

For the period October 2004 to September 2005, total sales of pharmaceutical companies in the Philippines was around P 85.2 billion, while for the period October 2003 to September 2004, total sales of pharmaceutical companies in the Philippines was around P 80.7 billion. Total sales for the period October 2004 to September 2005 grew by 5.57 percent compared to the period October 2003 to September 2004.

Total sales revenue of Optaderm during the said period was estimated to be P 22 million (not yet audited). This translates to a market share of 0.0258 percent for Optaderm in the pharmaceutical market during the said period.

Unilab continues to be the number one pharmaceutical company in the Philippines, followed by GlaxoSmithKline (2nd), and Pfizer Inc. (3rd). Ventolin continues to be the number one pharmaceutical product.

The amount spent on healthcare has consistently been a very small proportion of total household expenditure in the country, moving within a narrow range of 1% to 2% since 1991. There is practically no difference in proportion of healthcare expenditure between urban and rural households.

As of April 2003, there are a total of 20,649 pharmaceutical-related establishments nationwide, including drugstores and pharmacies. In fact, drugstores make up almost 75% of the total number of pharmaceutical establishments.

As of 2003, chain drugstores have more than half (59%) of the total share of products sold, and independent drugstores have 25 %. Other retail outlets are actually made up of dispensing physicians, large corporations who provide medication for their human resources (industrials), and clinics without beds.

Abstract Format

html

Language

English

Format

Electronic

Accession Number

CDOCE00942

Shelf Location

Archives, The Learning Commons, 12F Henry Sy Sr. Hall

Physical Description

1 computer optical disc ; 4 3/4 in.

Keywords

Pharmaceutical industry--Philippines; Strategic planning; Optaderm Pharma; Inc.

This document is currently not available here.

Share

COinS